Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhishek Puthenveetil

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|March 19, 2026
When science becomes personalAbhishek Puthenveetil
Annals of Translational Medicine|September 21, 2020
Metabolic reprograming of tumor-associated macrophagesAbhishek Puthenveetil, Shweta Dubey
Methods in Cell Biology|February 7, 2025
Isolation and characterization of primary NK cells and the enrichment of the KIR2DL1<sup>+</sup> populationBatel Sabag, Abhishek Puthenveetil, Mira Barda-Saad
Molecular Therapy. Methods & Clinical Development|December 16, 2025
Leveraging the active conformation of LFA-1 as a potential target for hematological malignanciesAbhishek Puthenveetil, Guy Biber, Batel Sabag, et al.
Cancers|August 12, 2022
Actin Retrograde Flow Regulated by the Wiskott-Aldrich Syndrome Protein Drives the Natural Killer Cell ResponseBatel Sabag, Moria Levy, Jessica Kivelevitz, et al.
The EMBO Journal|April 18, 2024
Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activityBatel Sabag, Abhishek Puthenveetil, Moria Levy, et al.
EMBO Molecular Medicine|November 2, 2021
Modulation of intrinsic inhibitory checkpoints using nano-carriers to unleash NK cell activityGuy Biber, Batel Sabag, Anat Raiff, et al.
Elife|March 8, 2022
Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicityAviad Ben-Shmuel, Batel Sabag, Abhishek Puthenveetil, et al.
Nature Communications|September 23, 2021
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignanciesGuy Biber, Aviad Ben-Shmuel, Elad Noy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|March 19, 2026
When science becomes personalAbhishek Puthenveetil
Annals of Translational Medicine|September 21, 2020
Metabolic reprograming of tumor-associated macrophagesAbhishek Puthenveetil, Shweta Dubey
Methods in Cell Biology|February 7, 2025
Isolation and characterization of primary NK cells and the enrichment of the KIR2DL1<sup>+</sup> populationBatel Sabag, Abhishek Puthenveetil, Mira Barda-Saad
Molecular Therapy. Methods & Clinical Development|December 16, 2025
Leveraging the active conformation of LFA-1 as a potential target for hematological malignanciesAbhishek Puthenveetil, Guy Biber, Batel Sabag, et al.
Cancers|August 12, 2022
Actin Retrograde Flow Regulated by the Wiskott-Aldrich Syndrome Protein Drives the Natural Killer Cell ResponseBatel Sabag, Moria Levy, Jessica Kivelevitz, et al.
The EMBO Journal|April 18, 2024
Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activityBatel Sabag, Abhishek Puthenveetil, Moria Levy, et al.
EMBO Molecular Medicine|November 2, 2021
Modulation of intrinsic inhibitory checkpoints using nano-carriers to unleash NK cell activityGuy Biber, Batel Sabag, Anat Raiff, et al.
Elife|March 8, 2022
Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicityAviad Ben-Shmuel, Batel Sabag, Abhishek Puthenveetil, et al.
Nature Communications|September 23, 2021
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignanciesGuy Biber, Aviad Ben-Shmuel, Elad Noy, et al.
Pageof 1